FAK and WNT signaling: The meeting of two pathways in cancer and development

Anti-Cancer Agents in Medicinal Chemistry

Volumn 11, Issue 7, 2011, Pages 600-606

  Fonar, Yuri ^a   Frank, Dale ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Cancer; Development; Focal adhesion kinase (FAK); Wnt catenin

Indexed keywords

BETA CATENIN; FOCAL ADHESION KINASE; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; WNT PROTEIN;

ARTICLE; BONE REMODELING; BREAST CANCER; CANCER CELL CULTURE; CARCINOGENESIS; COLON CANCER; COLORECTAL CANCER; EMBRYO DEVELOPMENT; ENZYME ACTIVITY; FIBROSING ALVEOLITIS; GENE EXPRESSION; HUMAN; INTESTINE; INTESTINE CANCER; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PANCREAS CANCER; PROTEIN DEPLETION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TISSUE REGENERATION; XENOPUS LAEVIS;

EID: 80051710743     PISSN: 18715206     EISSN: 18755992     Source Type: Journal    
DOI: 10.2174/187152011796817673     Document Type: Article

References (48)

1. Lim, S.T.; Chen, X.L.; Lim, Y.; Hanson, D.A.; Vo, T.T.; Howerton, K.; Larocque, N.; Fisher, S.J.; Schlaepfer, D.D.; Ilic, D. Nuclear FAK promotes cell proliferation and survival through FERMenhanced p53 degradation. Mol. Cell, 2008, 29, 9-22.
2. Golubovskaya, V.M.; Finch, R.; Cance, W.G. Direct interaction of the N-terminal domain of focal adhesion kinase with the Nterminal transactivation domain of p53. J. Biol. Chem., 2005, 280, 25008-25021.
3. Luo, S.W.; Zhang, C.; Zhang, B.; Kim, C.H.; Qiu, Y.Z.; Du, Q.S.; Mei, L.; Xiong, W.C. Regulation of heterochromatin remodelling and myogenin expression during muscle differentiation by FAK interaction with MBD2. EMBO J., 2009, 28, 2568-2582.
4. Zhao, J.; Pestell, R.; Guan, J.L. Transcriptional activation of cyclin D1 promoter by FAK contributes to cell cycle progression. Mol. Biol. Cell, 2001, 12, 4066-4077.
5. Zhao, J.; Bian, Z.C.; Yee, K.; Chen, B.P.; Chien, S.; Guan, J.L. Identification of transcription factor KLF8 as a downstream target of focal adhesion kinase in its regulation of cyclin D1 and cell cycle progression. Mol. Cell, 2003, 11, 1503-1515.
6. Cox, B.D.; Natarajan, M.; Stettner, M.R.; Gladson, C.L. New concepts regarding focal adhesion kinase promotion of cell migration and proliferation. J. Cell Biochem., 2006, 99, 35-52.
7. Golubovskaya, V.M.; Cance, W.G. Focal adhesion kinase and p53 signaling in cancer cells. Int. Rev. Cytol., 2007, 263, 103-153.
8. Golubovskaya, V.M.; Cance, W. Focal adhesion kinase and p53 signal transduction pathways in cancer. Front Biosci., 2010, 15, 901-912.
9. Provenzano, P.P.; Inman, D.R.; Eliceiri, K.W.; Beggs, H.E.; Keely, P.J. Mammary epithelial-specific disruption of focal adhesion kinase retards tumor formation and metastasis in a transgenic mouse model of human breast cancer. Am. J. Pathol., 2008, 173, 1551-1565.
10. Golubovskaya, V.M.; Zheng, M.; Zhang, L.; Li, J.L.; Cance, W.G. The direct effect of focal adhesion kinase (FAK), dominantnegative FAK, FAK-CD and FAK siRNA on gene expression and human MCF-7 breast cancer cell tumorigenesis. BMC Cancer, 2009, 9, 280.
11. Dunn, K.B.; Heffler, M.; Golubovskaya, V.M. Evolving therapies and FAK inhibitors for the treatment of cancer. Anticancer Agents Med. Chem., 2010, 10, 722-734.
12. Cohen, E.D.; Mariol, M.C.; Wallace, R.M.; Weyers, J.; Kamberov, Y.G.; Pradel, J.; Wilder, E.L. DWnt4 regulates cell movement and focal adhesion kinase during Drosophila ovarian morphogenesis. Dev Cell, 2002, 2, 437-448.
13. Fonar, Y.; Gutkovich, Y.E.; Root, H.; Malyarova, A.; Aamar, E.; Golubovskaya, V.M.; Elias, S.; Elkouby, Y.M.; Frank, D. Focal Adhesion Kinase protein regulates Wnt3a gene expression to control cell fate specification in the developing neural plate. Mol Biol Cell, 2011, 22, 2409-2421.
14. Elkouby, Y.M.; Elias, S.; Casey, E.S.; Blythe, S.A.; Tsabar, N.; Klein, P.S.; Root, H.; Liu, K.J.; Frank, D. Mesodermal Wnt signaling organizes the neural plate via Meis3. Development, 2010, 137, 1531-1541.
15. Santos, A.; Bakker, A.D.; Zandieh-Doulabi, B.; de Blieck- Hogervorst, J.M.; Klein-Nulend, J. Early activation of the betacatenin pathway in osteocytes is mediated by nitric oxide, phosphatidyl inositol-3 kinase/Akt, and focal adhesion kinase. Biochem Biophys Res Commun, 2010, 391, 364-369.
16. Bellido, T. Antagonistic interplay between mechanical forces and glucocorticoids in bone: a tale of kinases. J Cell Biochem, 2010, 111, 1-6.
17. Bonewald, L.F.; Johnson, M.L. Osteocytes, mechanosensing and Wnt signaling. Bone, 2008, 42, 606-615.
18. Case, N.; Ma, M.; Sen, B.; Xie, Z.; Gross, T.S.; Rubin, J. Betacatenin levels influence rapid mechanical responses in osteoblasts. J Biol Chem, 2008, 283, 29196-29205.
19. Norvell, S.M.; Alvarez, M.; Bidwell, J.P.; Pavalko, F.M. Fluid shear stress induces beta-catenin signaling in osteoblasts. Calcif. Tissue Int., 2004, 75, 396-404.
20. Robinson, J.A.; Chatterjee-Kishore, M.; Yaworsky, P.J.; Cullen, D.M.; Zhao, W.; Li, C.; Kharode, Y.; Sauter, L.; Babij, P.; Brown, E.L.; Hill, A.A.; Akhter, M.P.; Johnson, M.L.; Recker, R.R.; Komm, B.S.; Bex, F.J. Wnt/beta-catenin signaling is a normal physiological response to mechanical loading in bone. J. Biol. Chem., 2006, 281, 31720-31728.
21. Santos, A.; Bakker, A.D.; Zandieh-Doulabi, B.; Semeins, C.M.; Klein-Nulend, J. Pulsating fluid flow modulates gene expression of proteins involved in Wnt signaling pathways in osteocytes. J Orthop Res, 2009, 27, 1280-1287.
22. Plotkin, L.I.; Mathov, I.; Aguirre, J.I.; Parfitt, A.M.; Manolagas, S.C.; Bellido, T. Mechanical stimulation prevents osteocyte apoptosis: requirement of integrins, Src kinases, and ERKs. Am. J. Physiol. Cell Physiol., 2005, 289, C633-643.
23. Martin-Millan MPL., Vyas K, Frera G, Gortazar AR, Almeida M, Manolagas SC, Bellido T. Kinase activation and osteocyte survival promoted by mechanical stimulation require LRP5/6 signaling and β-catenin accumulation, but not β-catenin/TCF-dependent transcription. J. Bone Min. Res., 2008, 23:S400. (Abstr.).
24. Ashton, G.H.; Morton, J.P.; Myant, K.; Phesse, T.J.; Ridgway, R.A.; Marsh, V.; Wilkins, J.A.; Athineos, D.; Muncan, V.; Kemp, R.; Neufeld, K.; Clevers, H.; Brunton, V.; Winton, D.J.; Wang, X.; Sears, R.C.; Clarke, A.R.; Frame, M.C.; Sansom, O.J. Focal adhesion kinase is required for intestinal regeneration and tumorigenesis downstream of Wnt/c-Myc signaling. Dev. Cell, 2010, 19, 259-269.
25. Natarajan, M.; Stewart, J.E.; Golemis, E.A.; Pugacheva, E.N.; Alexandropoulos, K.; Cox, B.D.; Wang, W.; Grammer, J.R.; Gladson, C.L. HEF1 is a necessary and specific downstream effector of FAK that promotes the migration of glioblastoma cells. Oncogene, 2006, 25, 1721-1732.
26. Li, Y.; Bavarva, J.H.; Wang, Z.; Guo, J.; Qian, C.; Thibodeau, S.N.; Golemis, E.A.; Liu, W. HEF1, a novel target of Wnt signaling, promotes colonic cell migration and cancer progression. Oncogene, 2011.
27. Golubovskaya, V.; Kaur, A.; Cance, W. Cloning and characterization of the promoter region of human focal adhesion kinase gene: nuclear factor kappa B and p53 binding sites. Biochim. Biophys. Acta, 2004, 1678, 111-125.
28. Anaganti, S.; Fernandez-Cuesta, L.; Langerod, A.; Hainaut, P.; Olivier, M. p53-Dependent repression of focal adhesion kinase in response to estradiol in breast cancer cell-lines. Cancer Lett, 2011, 300, 215-224.
29. Katoh, M. Regulation of WNT3 and WNT3A mRNAs in human cancer cell lines NT2, MCF-7, and MKN45. Int. J. Oncol., 2002, 20, 373-377.
30. Humbert, M.; Casteran, N.; Letard, S.; Hanssens, K.; Iovanna, J.; Finetti, P.; Bertucci, F.; Bader, T.; Mansfield, C.D.; Moussy, A.; Hermine, O.; Dubreuil, P. Masitinib combined with standard gemcitabine chemotherapy: in vitro and in vivo studies in human pancreatic tumour cell lines and ectopic mouse model. PLoS One, 2010, 5, e9430.
31. Duxbury, M.S.; Ito, H.; Benoit, E.; Zinner, M.J.; Ashley, S.W.; Whang, E.E. RNA interference targeting focal adhesion kinase enhances pancreatic adenocarcinoma gemcitabine chemosensitivity. Biochem. Biophys. Res. Commun., 2003, 311, 786-792.
32. Dubreuil, P.; Letard, S.; Ciufolini, M.; Gros, L.; Humbert, M.; Casteran, N.; Borge, L.; Hajem, B.; Lermet, A.; Sippl, W.; Voisset, E.; Arock, M.; Auclair, C.; Leventhal, P.S.; Mansfield, C.D.; Moussy, A.; Hermine, O. Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT. PLoS One, 2009, 4, e7258.
33. Murtaugh, L.C. The what, where, when and how of Wnt/betacatenin signaling in pancreas development. Organogenesis, 2008, 4, 81-86.
34. Crampton, S.P.; Wu, B.; Park, E.J.; Kim, J.H.; Solomon, C.; Waterman, M.L.; Hughes, C.C. Integration of the beta-catenindependent Wnt pathway with integrin signaling through the adaptor molecule Grb2. PLoS One, 2009, 4, e7841.
35. Segarra, M.; Vilardell, C.; Matsumoto, K.; Esparza, J.; Lozano, E.; Serra-Pages, C.; Urbano-Marquez, A.; Yamada, K.M.; Cid, M.C. Dual function of focal adhesion kinase in regulating integrininduced MMP-2 and MMP-9 release by human T lymphoid cells. FASEB J., 2005, 19, 1875-1877.
36. Chilosi, M.; Poletti, V.; Zamo, A.; Lestani, M.; Montagna, L.; Piccoli, P.; Pedron, S.; Bertaso, M.; Scarpa, A.; Murer, B.; Cancellieri, A.; Maestro, R.; Semenzato, G.; Doglioni, C. Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis. Am. J. Pathol., 2003, 162, 1495-1502.
37. Henderson, W.R., Jr.; Chi, E.Y.; Ye, X.; Nguyen, C.; Tien, Y.T.; Zhou, B.; Borok, Z.; Knight, D.A.; Kahn, M. Inhibition of Wnt/beta-catenin/CREB binding protein (CBP) signaling reverses pulmonary fibrosis. Proc. Natl. Acad. Sci. USA, 2010, 107, 14309-14314.
38. Kim, T.H.; Kim, S.H.; Seo, J.Y.; Chung, H.; Kwak, H.J.; Lee, S.K.; Yoon, H.J.; Shin, D.H.; Park, S.S.; Sohn, J.W. Blockade of the Wnt/beta-catenin pathway attenuates bleomycin-induced pulmonary fibrosis. Tohoku J. Exp. Med., 2011, 223, 45-54.
39. Vittal, R.; Horowitz, J.C.; Moore, B.B.; Zhang, H.; Martinez, F.J.; Toews, G.B.; Standiford, T.J.; Thannickal, V.J. Modulation of prosurvival signaling in fibroblasts by a protein kinase inhibitor protects against fibrotic tissue injury. Am. J. Pathol., 2005, 166, 367-375.
40. Garneau-Tsodikova, S.; Thannickal, V.J. Protein kinase inhibitors in the treatment of pulmonary fibrosis. Curr. Med. Chem., 2008, 15, 2632-2640.
41. Cai, G.Q.; Zheng, A.; Tang, Q.; White, E.S.; Chou, C.F.; Gladson, C.L.; Olman, M.A.; Ding, Q. Downregulation of FAK-related non-kinase mediates the migratory phenotype of human fibrotic lung fibroblasts. Exp. Cell Res., 2010, 316, 1600-1609.
42. Schaller, M.D. Cellular functions of FAK kinases: insight into molecular mechanisms and novel functions. J. Cell Sci., 123, 1007-1013.
43. Jones, G.; Machado, J., Jr.; Merlo, A. Loss of focal adhesion kinase (FAK) inhibits epidermal growth factor receptor-dependent migration and induces aggregation of nh(2)-terminal FAK in the nuclei of apoptotic glioblastoma cells. Cancer Res., 2001, 61, 4978-4981.
44. Yi, X.P.; Wang, X.; Gerdes, A.M.; Li, F. Subcellular redistribution of focal adhesion kinase and its related nonkinase in hypertrophic myocardium. Hypertension, 2003, 41, 1317-1323.
45. Oloumi, A.; Syam, S.; Dedhar, S. Modulation of Wnt3a-mediated nuclear beta-catenin accumulation and activation by integrin-linked kinase in mammalian cells. Oncogene, 2006, 25, 7747-7757.
46. Novak, A.; Hsu, S.C.; Leung-Hagesteijn, C.; Radeva, G.; Papkoff, J.; Montesano, R.; Roskelley, C.; Grosschedl, R.; Dedhar, S. Cell adhesion and the integrin-linked kinase regulate the LEF-1 and beta-catenin signaling pathways. Proc. Natl. Acad. Sci. USA, 1998, 95, 4374-4379.
47. Huang, S.M.; Mishina, Y.M.; Liu, S.; Cheung, A.; Stegmeier, F.; Michaud, G.A.; Charlat, O.; Wiellette, E.; Zhang, Y.; Wiessner, S.; Hild, M.; Shi, X.; Wilson, C.J.; Mickanin, C.; Myer, V.; Fazal, A.; Tomlinson, R.; Serluca, F.; Shao, W.; Cheng, H.; Shultz, M.; Rau, C.; Schirle, M.; Schlegl, J.; Ghidelli, S.; Fawell, S.; Lu, C.; Curtis, D.; Kirschner, M.W.; Lengauer, C.; Finan, P.M.; Tallarico, J.A.; Bouwmeester, T.; Porter, J.A.; Bauer, A.; Cong, F. Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature, 2009, 461, 614-620.
48. Wang, H.; Hao, J.; Hong, C.C. Cardiac induction of embryonic stem cells by a small molecule inhibitor of Wnt/beta-catenin signaling. ACS Chem. Biol., 2011, 6, 192-197.